Features

PremiumFeatures

ICH GCP Annex 2 will strengthen sponsor confidence in the use of DCTs and RWD

In July 2026, the International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) quietly…

Features

Podcast: Bringing diversity to Alzheimer’s trials

Features

ASCO26: AI innovations show promise in reducing the oncology RWD burden

Features

Operation Trialblazer: Expedited IND delivers a strategic edge in dynamic global landscape

Features

AAIC26: Alzheimer’s disease heterogeneity calls for a rethink

Interviews

J&J’s Mark Graham on advancing nipocalimab as treatment for SLE

Features

Smarter data, faster decisions: How biotech funding pressures are reshaping clinical development

Features

UK bookmarks Spain’s success in race to global clinical trials competitiveness

Features

How wearables can unlock their full potential in clinical research

Features

Podcast: AI in oncology – the trials, tribulations and opportunities

Annabel Kartal Allen

AI

Clinical trial statistics gets an AI-era overhaul

Catherine Longworth

Features

Podcast: Championing the next generation of life sciences talent, a NIHR perspective

Annabel Kartal Allen

Features

ASCO26 Podcast: an analyst rundown of the best readouts and key trends

Annabel Kartal Allen

Features

FDA leadership in flux, but core operations remain stable, former FDA staff say

Features

Podcast: Experience as a patient in a first-in-human clinical trial

Features

H1 2026 clinical trials: China, funding and technology set the agenda

Features

Participant enrolment and retention key to clinical trial derisking

Features

Three PsA trials to watch in 2026

Annabel Kartal Allen

Features

Podcast: UK targets speedy clinical trial set-ups with 150-day benchmark

Features

Countries compete to reform trials in a bid to attract global sponsors

Features

Implementing AI in workflows: One step at a time

Features

Despite turbulence at FDA, technical staff remain “dedicated,” says CMO

Features

Wave of AI and data science tools set to transform clinical trials

Features

EU’s Joint Clinical Assessment system still finding its footing

Features

The slow march of clinical biomarkers to become surrogate endpoints

Frankie Fattorini

Features

Biomarker-led trials to guide the future of precision psychiatry

Annabel Kartal Allen

Features

Preparation is key to understanding global trade compliance for trials

Features

Trials to watch: Phase III TB vaccines and MDR-TB treatments

Features

Technology a key tool in successful clinical supply management

Features

Strong relationships among stakeholders key to clinical supply chain success

Features

Be nimble, be ready: how to tackle regulatory uncertainty in clinical trials

Features

Building for decades: Dubai’s long game in life sciences

Catherine Longworth

Features

Opening clinical trials to pregnant women

Features

Women first: the Gulf’s new healthcare blueprint

Catherine Longworth

Features

The clinical trial supply model of the future

Features

Podcast: Sanofi’s head of clinical supply chain operations on evolving the clinical trial supply model

Features

Podcast: Rare Disease Day: FDA guidance allowing advancement

Abigail Beaney , Robert Barrie and Frankie Fattorini

Features

Rare disease developers applaud clarity in FDA guidance

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close